Oxford Nanopore Technologies (LON:ONT) Stock Rating Reaffirmed by Berenberg Bank

Oxford Nanopore Technologies (LON:ONT)‘s stock had its “buy” rating reaffirmed by research analysts at Berenberg Bank in a research note issued on Wednesday, LSE.Co.UK reports. They presently have a GBX 350 ($4.36) price objective on the stock. Berenberg Bank’s price objective indicates a potential upside of 253.89% from the company’s current price.

Separately, Citigroup reissued a “buy” rating and issued a GBX 210 ($2.61) price target on shares of Oxford Nanopore Technologies in a research report on Friday, April 12th. Five investment analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has a consensus rating of “Buy” and a consensus target price of GBX 303.75 ($3.78).

Oxford Nanopore Technologies Stock Down 1.3 %

ONT traded down GBX 1.30 ($0.02) during midday trading on Wednesday, hitting GBX 98.90 ($1.23). 2,236,942 shares of the company’s stock traded hands, compared to its average volume of 889,819. The company has a market cap of £850.50 million, a PE ratio of -666.33 and a beta of 0.59. The stock’s fifty day simple moving average is GBX 133.17 and its 200-day simple moving average is GBX 169.54. The company has a debt-to-equity ratio of 6.47, a current ratio of 5.01 and a quick ratio of 6.01. Oxford Nanopore Technologies has a one year low of GBX 92.20 ($1.15) and a one year high of GBX 279 ($3.47).

Insider Transactions at Oxford Nanopore Technologies

In other Oxford Nanopore Technologies news, insider Gurdial (Gordon) Sanghera purchased 39,196 shares of the firm’s stock in a transaction on Wednesday, March 6th. The shares were purchased at an average price of GBX 127 ($1.58) per share, for a total transaction of £49,778.92 ($61,968.03). Over the last quarter, insiders have purchased 39,421 shares of company stock worth $5,007,852. Insiders own 30.07% of the company’s stock.

Oxford Nanopore Technologies Company Profile

Oxford Nanopore Technologies plc engages in the research, development, manufacture, and commercialization of a nanopore based sequencing platform that allows the real-time analysis of deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in the Americas, Europe, the Middle East, Africa, India, and the Asia Pacific.